Impact Companies Tag: Drug Development 1

• Companies (1) Investors (0) People (0) Services (0)

• Sort by:

• <  Back to All Tags

All or A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Company

Kymab

United Kingdom of Great Britain and Northern Irela

Kymab is discovering and developing fully human monoclonal antibody therapeutics using our pioneering Kymouse platform. Kymab is building a rich pipeline of assets in four therapeutic spaces immuno oncology inflammation haematology and infectious diseases.

Human health & social work

United Kingdom of Great Britain and Northern Irela

Access to Information

Add to ImpactSpace

Explore

• IMPACT COMPANIES 6,811

• IMPACT INVESTORS 3,556

• IMPACT DEALS 5,123

• PEOPLE 9,226

• IMPACT SERVICES 460